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HIV-1 DNA loadIn this issue of EBioMedicine, Ruggiero and colleagues describe immune activation biomarkers associated with
the size of the HIV reservoir in a carefully designed cross-sectional study. The cohort consists of a homogeneous
sample of HIV-1-infected patients with long-term plasmaHIV-1 RNA suppression under antiretroviral treatment
(ART). It is crucial to explore the potential utility of biomarkers that are easier (less labor intensive, less expen-
sive) to measure than integrated HIV DNA load, in order to quickly and accurately quantify cellular reservoirs
of HIV.
© 2015 The Author. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Commentary reservoir was measured by the quantiﬁcation of integrated HIV-1 DNAWhile current combination antiretroviral treatment (ART) success-
fully suppresses human immunodeﬁciency virus (HIV) replication, it
cannot eradicate the virus since HIV efﬁciently resides latently in
some cellular reservoirs, mainly resting CD4 T cells but also dendritic
cells and other cell types. It is known that HIV establishes a reservoir
of replication-competent integrated provirus early after infection that
is unresponsive to ART (Chavez et al., 2015; Martínez-Bonet et al.,
2015; Siliciano and Siliciano, 2015). Although the mechanism of HIV
persistence is not fully understood, proposed models focus on the con-
tinuous replenishment of the reservoir through ongoing virus produc-
tion, perhaps in sites where ART penetration or activity is suboptimal.
As an alternative, maintenance of the reservoir during ART can also
occur through proliferation of latently infected cells. Models have
also been proposed to explain persistent immune activation despite
ART, and include HIV-induced gut damage that allows translocation
of microbial products into the systemic circulation. Other persistent
infections, such as cytomegalovirus (CMV) or Epstein–Barr virus
(EBV), have also been linked to persistent immune activation. The
measurement of HIV reservoir includes the accurate quantiﬁcation
of integrated HIV-1 DNA in peripheral blood and other cells or tissues
(Archin et al., 2014).
The study by Ruggiero and colleagues describes factors associated
with the size of the HIV reservoir in a very well designed cross-
sectional study of a carefully selected and homogeneous sample of
HIV-1-infected patients with long-term plasma HIV-1 RNA suppression
under ART (Ruggiero et al., 2015). It is important to note that the study
cohort was uniform with respect to the initial ﬁrst-line antiretroviral
regimen and absence of viral blips for up to 14 years. The size of theom.2015.07.025.
. This is an open access article underas well as by 2-long terminal repeat circular HIV-1 DNA. Investigated
factors associated with the reservoir included residual plasma HIV-1
RNA and markers of immune activation on CD4 and CD8 T cells,
and also the quantiﬁcation of soluble CD14 as a marker of monocyte/
macrophage activation. The main ﬁnding of this study was a positive
association between the levels of integrated HIV-1 DNA in peripheral
blood and the frequency of CD8 T cells expressing HLA-DR/DP/DQ.
Furthermore, the lack of association between integrated HIV-1 DNA
load and CD8 and CD4 cells expressing CD38 indicates that the associa-
tion involves a distinct T cell activation proﬁle. The immune activation
marker, HLA-DR/DP/DQ, can therefore indirectly estimate theHIV reser-
voir in eradication strategies. This paper contributes to evidence that a
complex interplay between HIV-1 persistence and immune activation
continues over many years despite stably suppressive ART.
Although the function of CD8 T cells expressing HLA-DR/DP/DQ
(without CD38) needs to be further studied, both regulatory and effec-
tor functions may play a role. Crucially, CD8+HLADR/DP/DQ+ cells may
stimulate HIV-infected CD4 cells, causing expansion of the reservoir. As
the authors mentioned, it will be important to determine the antigenic
speciﬁcity of these cells and any possible activity against persistent
viruses such as CMV and EBV. These infections were not commonly
detected in the cohort studied and this observation would suggest im-
munological control. As the authors recommend, it will be important
to study CD8+CD38−HLA-DR/DP/DQ+ cells speciﬁcally, as they are
preferentially generated in response to low antigenic stimulation and
may play a role as elite controllers, suppressing HIV replication as well
as clearing hepatitis C infection.
New approaches to eradicate HIV infection, or at least to achieve a
“functional cure”, include the depletion of persistent infection, improve-
ment of the immune response and the disruption of latent infection
(Chun et al., 2015). For this purpose, it is crucial to develop accuratethe CC BY license (http://creativecommons.org/licenses/by/4.0/).
1021A. Vallejo / EBioMedicine 2 (2015) 1020–1021tools to directly quantify cellular reservoirs of HIV (Crooks et al., 2015),
or exploit immunological biomarkers to determine HIV persistence by
providing an indirect measure of the size of the reservoir as described
by Ruggiero and colleagues. In both cases, validation in multiple inde-
pendent cohorts is desirable in order to conﬁrm their scientiﬁc utility.
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